| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2133.1993.TB15139.X |
| P698 | PubMed publication ID | 7681315 |
| P50 | author | Jean-Philippe Lacour | Q43117617 |
| P2093 | author name string | J P Ortonne | |
| I Bodokh | |||
| J Castanet | |||
| S Bekri | |||
| P2860 | cites work | Familial and sporadic porphyria cutanea: two different diseases | Q41953376 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| hepatitis C | Q154869 | ||
| Hepatitis C virus | Q708693 | ||
| porphyria cutanea tarda | Q1479497 | ||
| P304 | page(s) | 121-123 | |
| P577 | publication date | 1993-02-01 | |
| P1433 | published in | British Journal of Dermatology | Q4970191 |
| P1476 | title | Porphyria cutanea tarda and antibodies to hepatitis C virus | |
| P478 | volume | 128 |
| Q42987473 | A pilot randomized, controlled trial of the effect of iron depletion on long-term response to α-interferon in patients with chronic hepatitis C |
| Q33759589 | An overview of sexually transmitted diseases. Part II. |
| Q62607272 | Autoantibodies to human cytosol: a marker of sporadic porphyria cutanea tarda |
| Q41745501 | Clinical Features of the Porphyrias |
| Q35960885 | Clinical manifestations of hepatitis C. |
| Q74026181 | Cutaneous abnormalities and metabolic disturbance of porphyrins in patients on maintenance haemodialysis |
| Q42987367 | Dramatic resolution of skin lesions associated with porphyria cutanea tarda after interferon-alpha therapy in a case of chronic hepatitis C |
| Q42986887 | Epidemiology of hepatitis C and G in sporadic and familial porphyria cutanea tarda. |
| Q34105114 | Erythropoietic and hepatic porphyrias |
| Q74694122 | Evaluation of porphyria |
| Q45746740 | Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. |
| Q45764259 | Geographical differences in prevalence of hepatitis C virus infection in PCT (porphyria cutanea tarda) |
| Q43038848 | HCV infection in porphyria cutanea tarda |
| Q43001747 | Hepatic porphyrin concentration and uroporphyrinogen decarboxylase activity in hepatitis C virus infection. |
| Q45757982 | Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: The influence of virus C infection |
| Q72810934 | Hepatitis C in patients with porphyria cutanea tarda |
| Q42977709 | Hepatitis C virus infection in patients with urticaria |
| Q41225114 | Hepatitis C virus infection: clinical aspects and treatment with interferon alfa |
| Q33363781 | Hepatitis C virus-associated extrahepatic manifestations: a review |
| Q41890505 | Hepatitis C- and HIV-induced porphyria cutanea tarda |
| Q36642065 | Hepatitis C: progress and problems |
| Q62607290 | High prevalence of the His63Asp HFE mutation in italian patients with porphyria cutanea tarda |
| Q71867881 | Irish Society of Gastroenterology winter meeting. Dublin, November 1994. Abstracts |
| Q34295124 | Liposoluble vitamins and naturally occurring carotenoids in porphyria cutanea tarda |
| Q43035596 | Mooren-type hepatitis C virus-associated corneal ulceration. |
| Q33498313 | Nonhepatic manifestations and combined diseases in HCV infection |
| Q43520693 | Porphyria cutanea tarda and hepatitis C virus infection |
| Q45748316 | Porphyria cutanea tarda and hepatitis C virus: a case-control study and meta-analysis of the literature |
| Q45783900 | Porphyria cutanea tarda in hepatitis C virus-infected blood donors |
| Q42988426 | Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in north america† |
| Q34097888 | Porphyria cutanea tarda. |
| Q39189271 | Porphyria cutanea tarda: an intriguing genetic disease and marker |
| Q44273951 | Porphyrin metabolism in hepatitis C infection |
| Q35217843 | Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis. |
| Q33502199 | Skin diseases associated with hepatitis C virus infection |
| Q33610809 | The cutaneous porphyrias: a review. The British Photodermatology Group |
| Q43047897 | The dermatopathologic manifestations of hepatitis C infection: a clinical, histological, and molecular assessment of 35 cases |
| Q43522902 | The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection |
| Q73013301 | [Familial porphyria cutanea tarda disclosed by chronic hepatitis C. Apropos of a case] |
Search more.